[S02DA03, antipyrine, The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Antipyrine is combined with Fosinopril.]
[B01AD01, streptokinase, The risk or severity of angioedema can be increased when Streptokinase is combined with Fosinopril.]
[J01GA01, streptomycin, Fosinopril may decrease the excretion rate of Streptomycin which could result in a higher serum level.]
[M03AB01, succinylcholine, The risk or severity of hyperkalemia can be increased when Succinylcholine is combined with Fosinopril.]
[A02BX02, sucralfate, Sucralfate may decrease the excretion rate of Fosinopril which could result in a higher serum level.]
[J01CG01, sulbactam, Fosinopril may decrease the excretion rate of Sulbactam which could result in a higher serum level.]
[J01EC02, sulfadiazine, Sulfadiazine may decrease the excretion rate of Fosinopril which could result in a higher serum level.]
[J01EC01, sulfamethoxazole, The risk or severity of hyperkalemia can be increased when Fosinopril is combined with Sulfamethoxazole.]
[M01AB02, sulindac, The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Sulindac is combined with Fosinopril.]
[M01AX04, apazone, The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Azapropazone is combined with Fosinopril.]
[N05CD07, temazepam, Temazepam may decrease the excretion rate of Fosinopril which could result in a higher serum level.]
[R03CC03, terbutaline, Terbutaline may decrease the antihypertensive activities of Fosinopril.]
[B01AE07, dabigatran etexilate, Fosinopril may decrease the excretion rate of Dabigatran etexilate which could result in a higher serum level.]
[G03BA03, testosterone, Fosinopril may decrease the excretion rate of Testosterone which could result in a higher serum level.]
[S03AA02, tetracycline, Fosinopril may decrease the excretion rate of Tetracycline which could result in a higher serum level.]
[J01DI02, ceftaroline fosamil, Ceftaroline fosamil may decrease the excretion rate of Fosinopril which could result in a higher serum level.]
[N05AE05, lurasidone, Lurasidone may decrease the antihypertensive activities of Fosinopril.]
[N04BC07, apomorphine, The risk or severity of adverse effects can be increased when Fosinopril is combined with Apomorphine.]
[L04AX02, thalidomide, The risk or severity of adverse effects can be increased when Fosinopril is combined with Thalidomide.]
[R03DA07, theobromine, Theobromine may increase the excretion rate of Fosinopril which could result in a lower serum level and potentially a reduction in efficacy.]
[P02CA02, thiabendazole, Fosinopril may decrease the excretion rate of Thiabendazole which could result in a higher serum level.]
[R06AD03, thiethylperazine, Thiethylperazine may decrease the excretion rate of Fosinopril which could result in a higher serum level.]
[N05CA19, thiopental, Thiopental may increase the hypotensive activities of Fosinopril.]
[N05AB08, thioproperazine, Thioproperazine may decrease the antihypertensive activities of Fosinopril.]
[N05AC02, thioridazine, Thioridazine may decrease the antihypertensive activities of Fosinopril.]
[B02AB01, aprotinin, Aprotinin may decrease the antihypertensive activities of Fosinopril.]
[G04BE06, moxisylyte, Moxisylyte may decrease the antihypertensive activities of Fosinopril.]
[N05AL03, tiapride, Fosinopril may decrease the excretion rate of Tiapride which could result in a higher serum level.]
[B01AC05, ticlopidine, Ticlopidine may decrease the excretion rate of Fosinopril which could result in a higher serum level.]
[S01ED01, timolol, Timolol may increase the hypotensive activities of Fosinopril.]
[P01AB02, tinidazole, Fosinopril may decrease the excretion rate of Tinidazole which could result in a higher serum level.]
[S01AA12, tobramycin, Fosinopril may decrease the excretion rate of Tobramycin which could result in a higher serum level.]
[A10BB05, tolazamide, Fosinopril may decrease the excretion rate of Tolazamide which could result in a higher serum level.]
[M02AX02, tolazoline, Tolazoline may decrease the antihypertensive activities of Fosinopril.]
[V04CA01, tolbutamide, Fosinopril may decrease the excretion rate of Tolbutamide which could result in a higher serum level.]
[M02AA21, tolmetin, The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Tolmetin is combined with Fosinopril.]
[N02AX02, tramadol, Tramadol may decrease the excretion rate of Fosinopril which could result in a higher serum level.]
[N06AF04, tranylcypromine, Tranylcypromine may increase the hypotensive activities of Fosinopril.]
[N06AX05, trazodone, Trazodone may decrease the antihypertensive activities of Fosinopril.]
[L01XF01, tretinoin, The risk or severity of adverse effects can be increased when Fosinopril is combined with Tretinoin.]
[C03DB02, triamterene, The risk or severity of hyperkalemia can be increased when Triamterene is combined with Fosinopril.]
[N05CD05, triazolam, Fosinopril may decrease the excretion rate of Triazolam which could result in a higher serum level.]
[C03AA06, trichlormethiazide, The therapeutic efficacy of Fosinopril can be increased when used in combination with Trichlormethiazide.]
[A16AX12, trientine, Fosinopril may decrease the excretion rate of Triethylenetetramine which could result in a higher serum level.]
[N05AB06, trifluoperazine, Trifluoperazine may decrease the antihypertensive activities of Fosinopril.]
[S01AD02, trifluridine, Trifluridine may decrease the excretion rate of Fosinopril which could result in a higher serum level.]
[A03AA05, trimebutine, The risk or severity of hyperkalemia can be increased when Fosinopril is combined with Trimebutine.]
[S01ED04, metipranolol, Fosinopril may increase the hypotensive activities of Metipranolol.]
[N03AC02, trimethadione, The risk or severity of hyperkalemia can be increased when Trimethadione is combined with Fosinopril.]
[C02BA01, trimethaphan, Fosinopril may increase the hypotensive activities of Trimethaphan.]
[J01EA01, trimethoprim, Trimethoprim may increase the hyperkalemic activities of Fosinopril.]
[N06AA06, trimipramine, Trimipramine may decrease the antihypertensive activities of Fosinopril.]
[N06AX24, vilazodone, Vilazodone may decrease the antihypertensive activities of Fosinopril.]
[C09CA09, azilsartan medoxomil, The risk or severity of renal failure, hypotension, and hyperkalemia can be increased when Fosinopril is combined with Azilsartan medoxomil.]
[R03DX07, roflumilast, Fosinopril may decrease the excretion rate of Roflumilast which could result in a higher serum level.]
[L01FX04, ipilimumab, Fosinopril may decrease the excretion rate of Ipilimumab which could result in a higher serum level.]
[R02AA14, oxyquinoline, Fosinopril may decrease the excretion rate of Oxyquinoline which could result in a higher serum level.]
[A10BH05, linagliptin, The risk or severity of angioedema can be increased when Linagliptin is combined with Fosinopril.]
[B01AD04, urokinase, The risk or severity of angioedema can be increased when Urokinase is combined with Fosinopril.]
[S01AA28, vancomycin, Fosinopril may decrease the excretion rate of Vancomycin which could result in a higher serum level.]
[N03AX21, ezogabine, Fosinopril may decrease the excretion rate of Ezogabine which could result in a higher serum level.]
[B01AF01, rivaroxaban, Fosinopril may decrease the excretion rate of Rivaroxaban which could result in a higher serum level.]
[R03AC18, indacaterol, Indacaterol may decrease the antihypertensive activities of Fosinopril.]
[C08DA01, verapamil, The risk or severity of adverse effects can be increased when Fosinopril is combined with Verapamil.]
[N06AX09, viloxazine, Fosinopril may decrease the excretion rate of Viloxazine which could result in a higher serum level.]
[C04AX07, vincamine, Fosinopril may increase the hypotensive activities of Vincamine.]
[B03BA01, vitamin B12, Cyanocobalamin may decrease the excretion rate of Fosinopril which could result in a higher serum level.]
[B01AA03, warfarin, Fosinopril may decrease the excretion rate of Warfarin which could result in a higher serum level.]
[N01AX15, xenon, Xenon may decrease the antihypertensive activities of Fosinopril.]
[C03BA10, xipamide, Xipamide may increase the excretion rate of Fosinopril which could result in a lower serum level and potentially a reduction in efficacy.]
[N05AF05, zuclopenthixol, Zuclopenthixol may decrease the antihypertensive activities of Fosinopril.]
[M05BA03, pamidronic acid, Pamidronic acid may decrease the excretion rate of Fosinopril which could result in a higher serum level.]
[M05BA05, tiludronic acid, Fosinopril may decrease the excretion rate of Tiludronic acid which could result in a higher serum level.]
[B06AC02, icatibant, Icatibant may decrease the antihypertensive activities of Fosinopril.]
[A02BC04, rabeprazole, Fosinopril may decrease the excretion rate of Rabeprazole which could result in a higher serum level.]
[N05AE04, ziprasidone, Ziprasidone may increase the antihypertensive activities of Fosinopril.]
[G03AC10, drospirenone, Fosinopril may increase the hyperkalemic activities of Drospirenone.]
[V03AC02, deferiprone, Fosinopril may decrease the excretion rate of Deferiprone which could result in a higher serum level.]
[N02BA01, aspirin, The therapeutic efficacy of Fosinopril can be decreased when used in combination with Acetylsalicylic acid.]
[L01EJ01, ruxolitinib, Fosinopril may decrease the excretion rate of Ruxolitinib which could result in a higher serum level.]
[G04BD07, tolterodine, Fosinopril may decrease the excretion rate of Tolterodine which could result in a higher serum level.]
[J01DH04, doripenem, Fosinopril may decrease the excretion rate of Doripenem which could result in a higher serum level.]
[C07AB03, atenolol, Atenolol may increase the hypotensive activities of Fosinopril.]
[L01FA01, rituximab, Fosinopril may increase the hypotensive activities of Rituximab.]
[S01FA01, atropine, Atropine may decrease the antihypertensive activities of Fosinopril.]
[M01CB03, auranofin, Fosinopril may decrease the excretion rate of Auranofin which could result in a higher serum level.]
[B03XA04, peginesatide, Fosinopril may decrease the excretion rate of Peginesatide which could result in a higher serum level.]
[L01BC07, azacitidine, Fosinopril may decrease the excretion rate of Azacitidine which could result in a higher serum level.]
[L04AX01, azathioprine, The risk or severity of myelosuppression, anemia, and severe leukopenia can be increased when Fosinopril is combined with Azathioprine.]
[L01BC05, gemcitabine, Gemcitabine may decrease the excretion rate of Fosinopril which could result in a higher serum level.]
[J01DF01, aztreonam, Aztreonam may decrease the excretion rate of Fosinopril which could result in a higher serum level.]
[R02AB04, bacitracin, Bacitracin may decrease the excretion rate of Fosinopril which could result in a higher serum level.]
[G04BE10, avanafil, Fosinopril may increase the hypotensive activities of Avanafil.]
[M03BX01, baclofen, The risk or severity of adverse effects can be increased when Baclofen is combined with Fosinopril.]
[A08AA11, lorcaserin, Fosinopril may decrease the excretion rate of Lorcaserin which could result in a higher serum level.]
[G04BD12, mirabegron, Mirabegron may decrease the antihypertensive activities of Fosinopril.]
[L02BB04, enzalutamide, Fosinopril may decrease the excretion rate of Enzalutamide which could result in a higher serum level.]
[C01CA18, octopamine, Octopamine may decrease the antihypertensive activities of Fosinopril.]
[N05CA04, barbital, Barbital may increase the hypotensive activities of Fosinopril.]
[D02BA02, octinoxate, Fosinopril may decrease the excretion rate of Octinoxate which could result in a higher serum level.]
[S01GA07, brimonidine, Brimonidine may increase the antihypertensive activities of Fosinopril.]
[N04BD02, rasagiline, Rasagiline may increase the hypotensive activities of Fosinopril.]
[C08CA13, lercanidipine, Fosinopril may increase the hypotensive activities of Lercanidipine.]
[N02CC03, zolmitriptan, Zolmitriptan may decrease the antihypertensive activities of Fosinopril.]
[V09IX04, fluorodeoxyglucose F18, Fosinopril may decrease the excretion rate of Fludeoxyglucose (18F) which could result in a higher serum level.]
[N01AA01, ethyl ether, Diethyl ether may decrease the antihypertensive activities of Fosinopril.]
[G04BE03, sildenafil, Sildenafil may increase the antihypertensive activities of Fosinopril.]
[V08CA11, gadofosveset, Fosinopril may decrease the excretion rate of Gadofosveset trisodium which could result in a higher serum level.]
[A16AX08, teduglutide, Fosinopril may decrease the excretion rate of Teduglutide which could result in a higher serum level.]
[C04AX11, bencyclane, The risk or severity of hyperkalemia can be increased when Fosinopril is combined with Bencyclane.]
[A10BH04, alogliptin, The risk or severity of angioedema can be increased when Alogliptin is combined with Fosinopril.]
[A16AX09, glycerol phenylbutyrate, Fosinopril may decrease the excretion rate of Glycerol phenylbutyrate which could result in a higher serum level.]
[C03AA01, bendroflumethiazide, The therapeutic efficacy of Fosinopril can be increased when used in combination with Bendroflumethiazide.]
[L04AX06, pomalidomide, Fosinopril may decrease the excretion rate of Pomalidomide which could result in a higher serum level.]
[N02BA10, benorilate, The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Benorilate is combined with Fosinopril.]
[A10BK02, canagliflozin, The risk or severity of renal failure, hypotension, and hyperkalemia can be increased when Canagliflozin is combined with Fosinopril.]
[A10AE05, insulin detemir, The risk or severity of hypoglycemia can be increased when Fosinopril is combined with Insulin detemir.]
[L03AA12, ancestim, Fosinopril may decrease the excretion rate of Ancestim which could result in a higher serum level.]
[M01AH01, celecoxib, The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Celecoxib is combined with Fosinopril.]
[N02CC02, naratriptan, Naratriptan may decrease the antihypertensive activities of Fosinopril.]
[L04AA18, everolimus, The risk or severity of adverse effects can be increased when Everolimus is combined with Fosinopril.]
[N04AC01, benztropine, Benzatropine may decrease the excretion rate of Fosinopril which could result in a higher serum level.]
[R02AX03, benzydamine, The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Benzydamine is combined with Fosinopril.]
[L01EE01, trametinib, Fosinopril may decrease the excretion rate of Trametinib which could result in a higher serum level.]
[V09AX05, florbetapir F-18, Fosinopril may decrease the excretion rate of Florbetapir (18F) which could result in a higher serum level.]
[N06AX28, levomilnacipran, Fosinopril may decrease the excretion rate of Levomilnacipran which could result in a higher serum level.]
[C08EA02, bepridil, Fosinopril may increase the hypotensive activities of Bepridil.]
[C02KX05, riociguat, Fosinopril may increase the hypotensive activities of Riociguat.]
[A10BJ03, lixisenatide, Fosinopril may decrease the excretion rate of Lixisenatide which could result in a higher serum level.]
[C02KX04, macitentan, Fosinopril may increase the hypotensive activities of Macitentan.]
[N06AX26, vortioxetine, Vortioxetine may decrease the antihypertensive activities of Fosinopril.]
[G03AC08, etonogestrel, Etonogestrel may decrease the excretion rate of Fosinopril which could result in a higher serum level.]
[J05AP08, sofosbuvir, Fosinopril may decrease the excretion rate of Sofosbuvir which could result in a higher serum level.]
[A10BK01, dapagliflozin, The risk or severity of renal failure, hypotension, and hyperkalemia can be increased when Dapagliflozin is combined with Fosinopril.]
[C01CA27, droxidopa, Droxidopa may decrease the antihypertensive activities of Fosinopril.]
[C07AB04, acebutolol, Fosinopril may increase the hypotensive activities of Acebutolol.]
[N05CH03, tasimelteon, Fosinopril may decrease the excretion rate of Tasimelteon which could result in a higher serum level.]
[L04AA32, apremilast, Fosinopril may decrease the excretion rate of Apremilast which could result in a higher serum level.]
[L02BG02, formestane, Fosinopril may decrease the excretion rate of Formestane which could result in a higher serum level.]
[S01ED02, betaxolol, Betaxolol may increase the hypotensive activities of Fosinopril.]
[V03AB34, fomepizole, Fosinopril may decrease the excretion rate of Fomepizole which could result in a higher serum level.]
[C02CC01, bethanidine, Bethanidine may decrease the antihypertensive activities of Fosinopril.]
[A10BK03, empagliflozin, The risk or severity of renal failure, hypotension, and hyperkalemia can be increased when Empagliflozin is combined with Fosinopril.]
[R03AC19, olodaterol, Olodaterol may decrease the antihypertensive activities of Fosinopril.]
[V08AA01, diatrizoic acid, Diatrizoate may decrease the excretion rate of Fosinopril which could result in a higher serum level.]
[S01EE02, unoprostone, Fosinopril may increase the hypotensive activities of Unoprostone.]
[V08AA04, iothalamic acid, Diatrizoate may decrease the excretion rate of Fosinopril which could result in a higher serum level.]
[S01AA15, dihydrostreptomycin, Dihydrostreptomycin may decrease the excretion rate of Fosinopril which could result in a higher serum level.]
[N05AA04, acepromazine, Acepromazine may decrease the antihypertensive activities of Fosinopril.]
[S03AA06, gentamicin, Fosinopril may decrease the excretion rate of Gentamicin which could result in a higher serum level.]
[B01AF03, edoxaban, Fosinopril may decrease the excretion rate of Edoxaban which could result in a higher serum level.]
[N06AX11, mirtazapine, Mirtazapine may decrease the antihypertensive activities of Fosinopril.]
[N02BE01, acetaminophen, Acetaminophen may decrease the excretion rate of Fosinopril which could result in a higher serum level.]
[L01DC01, bleomycin, Bleomycin may decrease the excretion rate of Fosinopril which could result in a higher serum level.]
[J05AF08, adefovir dipivoxil, Adefovir dipivoxil may decrease the excretion rate of Fosinopril which could result in a higher serum level.]
[N05AX16, brexpiprazole, Brexpiprazole may decrease the antihypertensive activities of Fosinopril.]
[G02CX02, flibanserin, Flibanserin may decrease the antihypertensive activities of Fosinopril.]
[N05AX15, cariprazine, Cariprazine may decrease the antihypertensive activities of Fosinopril.]
[M02AA25, aceclofenac, The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Aceclofenac is combined with Fosinopril.]
[M01AB11, acemetacin, The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Acemetacin is combined with Fosinopril.]
[S01EC01, acetazolamide, Acetazolamide may increase the excretion rate of Fosinopril which could result in a lower serum level and potentially a reduction in efficacy.]
[A10AE06, insulin degludec, The risk or severity of hypoglycemia can be increased when Fosinopril is combined with Insulin degludec.]
[V03AB37, idarucizumab, Fosinopril may decrease the excretion rate of Idarucizumab which could result in a higher serum level.]
[J05AF13, tenofovir alafenamide, The serum concentration of Tenofovir alafenamide can be increased when it is combined with Fosinopril.]
[L01XG03, ixazomib, Fosinopril may decrease the excretion rate of Ixazomib which could result in a higher serum level.]
[B01AC27, selexipag, Fosinopril may increase the hypotensive activities of Selexipag.]
[G04CA01, alfuzosin, Alfuzosin may increase the hypotensive activities of Fosinopril.]
[M04AB05, lesinurad, Fosinopril may decrease the excretion rate of Lesinurad which could result in a higher serum level.]
[M01AE16, alminoprofen, The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Alminoprofen is combined with Fosinopril.]
[N02BA02, aloxiprin, The risk or severity of renal failure can be increased when Aloxiprin is combined with Fosinopril.]
[N03AX23, brivaracetam, Fosinopril may decrease the excretion rate of Brivaracetam which could result in a higher serum level.]
[N05BA08, bromazepam, Fosinopril may decrease the excretion rate of Bromazepam which could result in a higher serum level.]
[N04BC01, bromocriptine, Bromocriptine may decrease the antihypertensive activities of Fosinopril.]
[A02AD05, aluminum magnesium silicate, Fosinopril may decrease the excretion rate of Almasilate which could result in a higher serum level.]
[N06AA19, amineptin, Amineptine may decrease the antihypertensive activities of Fosinopril.]
[C08CA01, amlodipine, Amlodipine may increase the hypotensive activities of Fosinopril.]
[C03CA02, bumetanide, Bumetanide may increase the excretion rate of Fosinopril which could result in a lower serum level and potentially a reduction in efficacy.]
[N01BB01, bupivacaine, The risk or severity of adverse effects can be increased when Bupivacaine is combined with Fosinopril.]
[C07AA19, bupranolol, Fosinopril may increase the hypotensive activities of Bupranolol.]
[N05BE01, buspirone, Buspirone may decrease the antihypertensive activities of Fosinopril.]
[L01XX27, arsenic trioxide, The risk or severity of adverse effects can be increased when Fosinopril is combined with Arsenic trioxide.]
[M02AA03, clofezone, Fosinopril may decrease the excretion rate of Rabeprazole which could result in a higher serum level.]
[A07EC04, balsalazide, The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Balsalazide is combined with Fosinopril.]
[R03CC12, bambuterol, Bambuterol may decrease the antihypertensive activities of Fosinopril.]
[A06AH05, naldemedine, Fosinopril may decrease the excretion rate of Naldemedine which could result in a higher serum level.]
[N07XX16, deutetrabenazine, Fosinopril may decrease the excretion rate of Deutetrabenazine which could result in a higher serum level.]
[N02BF02, pregabalin, The risk or severity of angioedema can be increased when Pregabalin is combined with Fosinopril.]
[C09AA07, benazepril, The risk or severity of angioedema can be increased when Fosinopril is combined with Benazepril.]
[P01CA02, benznidazole, Fosinopril may decrease the excretion rate of Benznidazole which could result in a higher serum level.]
[J01XX08, linezolid, Linezolid may increase the hypotensive activities of Fosinopril.]
[J05AF06, abacavir, Fosinopril may decrease the excretion rate of Abacavir which could result in a higher serum level.]
[N07XX13, valbenazine, Fosinopril may decrease the excretion rate of Valbenazine which could result in a higher serum level.]
[N04BD03, safinamide, Safinamide may increase the hypotensive activities of Fosinopril.]
[J01MA23, delafloxacin, Fosinopril may decrease the excretion rate of Delafloxacin which could result in a higher serum level.]
[L01BC06, capecitabine, Fosinopril may decrease the excretion rate of Capecitabine which could result in a higher serum level.]
[C07AB07, bisoprolol, Fosinopril may increase the hypotensive activities of Bisoprolol.]
[R03AC17, bitolterol, Bitolterol may decrease the antihypertensive activities of Fosinopril.]
[J01DC10, cefprozil, Cefprozil may decrease the excretion rate of Fosinopril which could result in a higher serum level.]
[C07AA17, bopindolol, The risk or severity of hyperkalemia can be increased when Fosinopril is combined with Bopindolol.]
[C01DX19, nesiritide, The risk or severity of adverse effects can be increased when Fosinopril is combined with Nesiritide.]
[C03DA03, canrenone, The risk or severity of hyperkalemia can be increased when Canrenone is combined with Fosinopril.]
[R03BA02, budesonide, Fosinopril may decrease the excretion rate of Budesonide which could result in a higher serum level.]
[C04AX20, buflomedil, Buflomedil may decrease the antihypertensive activities of Fosinopril.]
[M01AB07, bumadizone, The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Bumadizone is combined with Fosinopril.]
[N06AA15, butriptyline, Butriptyline may decrease the antihypertensive activities of Fosinopril.]
[A10BK04, ertugliflozin, The risk or severity of renal failure, hypotension, and hyperkalemia can be increased when Ertugliflozin is combined with Fosinopril.]
[R06AX18, acrivastine, Fosinopril may decrease the excretion rate of Acrivastine which could result in a higher serum level.]
[C09AA01, captopril, The risk or severity of angioedema can be increased when Fosinopril is combined with Captopril.]
[L02BB05, apalutamide, Fosinopril may decrease the excretion rate of Apalutamide which could result in a higher serum level.]
[N03AF01, carbamazepine, Fosinopril may decrease the excretion rate of Carbamazepine which could result in a higher serum level.]
[C07AG02, carvedilol, Fosinopril may increase the hypotensive activities of Carvedilol.]
[B02BX09, fostamatinib, Fostamatinib may increase the antihypertensive activities of Fosinopril.]
[N03AX24, cannabidiol, Cannabidiol may decrease the antihypertensive activities of Fosinopril.]
[L04AA37, baricitinib, Fosinopril may decrease the excretion rate of Baricitinib which could result in a higher serum level.]
[J01DE01, cefepime, Cefepime may decrease the excretion rate of Fosinopril which could result in a higher serum level.]
[J01DD10, cefetamet, Cefetamet may decrease the excretion rate of Fosinopril which could result in a higher serum level.]
[J01DD09, cefodizime, Cefodizime may decrease the excretion rate of Fosinopril which could result in a higher serum level.]
[J01DC11, ceforanide, Ceforanide may decrease the excretion rate of Fosinopril which could result in a higher serum level.]
[J01DD13, cefpodoxime, Cefpodoxime may decrease the excretion rate of Fosinopril which could result in a higher serum level.]
[J01DD14, ceftibuten, Ceftibuten may decrease the excretion rate of Fosinopril which could result in a higher serum level.]
[J01GB14, plazomicin, Fosinopril may decrease the excretion rate of Plazomicin which could result in a higher serum level.]
[C07AB08, celiprolol, Fosinopril may increase the hypotensive activities of Celiprolol.]
[A16AX14, migalastat, Fosinopril may decrease the excretion rate of Migalastat which could result in a higher serum level.]
[N03AX17, stiripentol, Fosinopril may decrease the excretion rate of Stiripentol which could result in a higher serum level.]
[S01GX12, cetirizine, Cetirizine may decrease the excretion rate of Fosinopril which could result in a higher serum level.]
[D08AE05, chloroxylenol, Fosinopril may decrease the excretion rate of Chloroxylenol which could result in a higher serum level.]
[M01AC05, lornoxicam, The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Lornoxicam is combined with Fosinopril.]
[N07XX15, inotersen, Inotersen may decrease the excretion rate of Fosinopril which could result in a higher serum level.]
[L01AD01, carmustine, Carmustine may decrease the excretion rate of Fosinopril which could result in a higher serum level.]
[A06AX05, prucalopride, Fosinopril may decrease the excretion rate of Prucalopride which could result in a higher serum level.]
[C09AA08, cilazapril, The risk or severity of angioedema can be increased when Fosinopril is combined with Cilazapril.]
[B01AC23, cilostazol, Fosinopril may decrease the excretion rate of Cilostazol which could result in a higher serum level.]
[A03FA08, cinitapride, Cinitapride may decrease the antihypertensive activities of Fosinopril.]
[S01ED05, carteolol, Fosinopril may increase the hypotensive activities of Carteolol.]
[L04AA42, siponimod, Siponimod may decrease the antihypertensive activities of Fosinopril.]
[N06BA14, solriamfetol, Solriamfetol may decrease the antihypertensive activities of Fosinopril.]
[N05BA09, clobazam, Clobazam may decrease the excretion rate of Fosinopril which could result in a higher serum level.]
[C09CA06, candesartan, The risk or severity of renal failure, hypotension, and hyperkalemia can be increased when Fosinopril is combined with Candesartan.]
[J01DC04, cefaclor, Cefaclor may decrease the excretion rate of Fosinopril which could result in a higher serum level.]
[J01DB05, cefadroxil, Cefadroxil may decrease the excretion rate of Fosinopril which could result in a higher serum level.]
[J01DC03, cefamandole, Cefamandole may decrease the excretion rate of Fosinopril which could result in a higher serum level.]
[J01DB07, cefatrizine, Cefatrizine may decrease the excretion rate of Fosinopril which could result in a higher serum level.]
[J01DB04, cefazolin, Cefazolin may decrease the excretion rate of Fosinopril which could result in a higher serum level.]
[J01DC09, cefmetazole, Cefmetazole may decrease the excretion rate of Fosinopril which could result in a higher serum level.]
[J01DC06, cefonicid, Cefonicid may decrease the excretion rate of Fosinopril which could result in a higher serum level.]
[J01DD12, cefoperazone, Cefoperazone may decrease the excretion rate of Fosinopril which could result in a higher serum level.]
[J01DD01, cefotaxime, Cefotaxime may decrease the excretion rate of Fosinopril which could result in a higher serum level.]
[J01DC05, cefotetan, Cefotetan may decrease the excretion rate of Fosinopril which could result in a higher serum level.]
[J01DC07, cefotiam, Cefotiam may decrease the excretion rate of Fosinopril which could result in a higher serum level.]
[J01DC01, cefoxitin, Cefoxitin may decrease the excretion rate of Fosinopril which could result in a higher serum level.]
[J01DD03, cefsulodin, Cefsulodin may decrease the excretion rate of Fosinopril which could result in a higher serum level.]
[J01DD02, ceftazidime, Ceftazidime may decrease the excretion rate of Fosinopril which could result in a higher serum level.]
[C03BX03, cicletanine, Cicletanine may increase the excretion rate of Fosinopril which could result in a lower serum level and potentially a reduction in efficacy.]
[J01DD07, ceftizoxime, Ceftizoxime may decrease the excretion rate of Fosinopril which could result in a higher serum level.]
[J01DD04, ceftriaxone, Ceftriaxone may decrease the excretion rate of Fosinopril which could result in a higher serum level.]
[S01AA27, cefuroxime, Cefuroxime may decrease the excretion rate of Fosinopril which could result in a higher serum level.]
[N07XX11, pitolisant, Fosinopril may decrease the excretion rate of Pitolisant which could result in a higher serum level.]
[C03AA09, cyclothiazide, The therapeutic efficacy of Fosinopril can be increased when used in combination with Cyclothiazide.]
[G04BE04, yohimbine, Yohimbine may decrease the antihypertensive activities of Fosinopril.]
[A10AE03, insulin, regular, pork, The risk or severity of hypoglycemia can be increased when Fosinopril is combined with Insulin pork.]
[J01XX09, daptomycin, Daptomycin may decrease the excretion rate of Fosinopril which could result in a higher serum level.]
[J01DB01, cephalexin, Cephalexin may decrease the excretion rate of Fosinopril which could result in a higher serum level.]
[J01DB02, cephaloridine, Cefaloridine may decrease the excretion rate of Fosinopril which could result in a higher serum level.]
[J01DB03, cephalothin, Cefalotin may decrease the excretion rate of Fosinopril which could result in a higher serum level.]
[J01DB08, cephapirin, Cefapirin may decrease the excretion rate of Fosinopril which could result in a higher serum level.]
[J01DB09, cephradine, Cefradine may decrease the excretion rate of Fosinopril which could result in a higher serum level.]
[A16AX16, givosiran, Givosiran may decrease the excretion rate of Fosinopril which could result in a higher serum level.]
[M09AX08, golodirsen, Fosinopril may decrease the excretion rate of Golodirsen which could result in a higher serum level.]
[S01XA12, dexpanthenol, Fosinopril may decrease the excretion rate of Dexpanthenol which could result in a higher serum level.]
[N02CC07, frovatriptan, Frovatriptan may decrease the antihypertensive activities of Fosinopril.]
[G04CB02, dutasteride, Dutasteride may decrease the antihypertensive activities of Fosinopril.]
[R02AA03, dichlorobenzyl alcohol, Fosinopril may decrease the excretion rate of Dichlorobenzyl alcohol which could result in a higher serum level.]
[G03DB08, dienogest, Fosinopril may decrease the excretion rate of Dienogest which could result in a higher serum level.]
[N02CC06, eletriptan, Eletriptan may decrease the antihypertensive activities of Fosinopril.]
[M01AH02, rofecoxib, The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Rofecoxib is combined with Fosinopril.]
[C08CA16, clevidipine, The risk or severity of adverse effects can be increased when Fosinopril is combined with Clevidipine.]
[C01BD07, dronedarone, Dronedarone may decrease the antihypertensive activities of Fosinopril.]
[V03AE03, lanthanum carbonate, Lanthanum carbonate can cause a decrease in the absorption of Fosinopril resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[C02AA06, methoserpidine, Fosinopril may increase the hypotensive activities of Methoserpidine.]
[N04BX04, opicapone, The risk or severity of adverse effects can be increased when Fosinopril is combined with Opicapone.]
[C01CA14, dopexamine, Dopexamine may decrease the antihypertensive activities of Fosinopril.]
[M01AC04, droxicam, The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Droxicam is combined with Fosinopril.]
[V08CA05, mangafodipir, Fosinopril may decrease the excretion rate of Mangafodipir which could result in a higher serum level.]
[L01EX22, selpercatinib, Selpercatinib may decrease the antihypertensive activities of Fosinopril.]
[M02AA27, dexketoprofen, The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Dexketoprofen is combined with Fosinopril.]
[C08CA17, levamlodipine, Fosinopril may increase the hypotensive activities of Levamlodipine.]
[P01BA01, chloroquine, Fosinopril may decrease the excretion rate of Chloroquine which could result in a higher serum level.]
[C03AA04, chlorothiazide, The therapeutic efficacy of Fosinopril can be increased when used in combination with Chlorothiazide.]
[N05AA01, chlorpromazine, Chlorpromazine may decrease the antihypertensive activities of Fosinopril.]
[A10BB02, chlorpropamide, Fosinopril may decrease the excretion rate of Chlorpropamide which could result in a higher serum level.]
[C03BA04, chlorthalidone, The risk or severity of hypotension can be increased when Chlorthalidone is combined with Fosinopril.]
[M03BB03, chlorzoxazone, Chlorzoxazone may decrease the excretion rate of Fosinopril which could result in a higher serum level.]
[N02BA07, ethenzamide, The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Ethenzamide is combined with Fosinopril.]
[N02BA03, choline salicylate, The risk or severity of renal failure can be increased when Choline salicylate is combined with Fosinopril.]
[N06BX18, vinpocetine, The risk or severity of hyperkalemia can be increased when Fosinopril is combined with Vinpocetine.]
[M01AB08, etodolac, The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Etodolac is combined with Fosinopril.]
[M02AA06, etofenamate, The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Etofenamate is combined with Fosinopril.]
[M01AX25, chondroitin sulfates, Fosinopril may decrease the excretion rate of Chondroitin sulfate which could result in a higher serum level.]
[L01FX21, naxitamab, Naxitamab may decrease the antihypertensive activities of Fosinopril.]
[C01DX22, vericiguat, The risk or severity of adverse effects can be increased when Fosinopril is combined with Vericiguat.]
[M01AE05, fenbufen, The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Fenbufen is combined with Fosinopril.]
[C01CA19, fenoldopam, Fosinopril may increase the hypotensive activities of Fenoldopam.]
[N06BA08, fenozolone, Fenozolone may decrease the antihypertensive activities of Fosinopril.]
[G04CB01, finasteride, Finasteride may decrease the antihypertensive activities of Fosinopril.]
[J01DD15, cefdinir, Fosinopril may decrease the excretion rate of Cefdinir which could result in a higher serum level.]
[S02BA08, fluocinolone acetonide, Fosinopril may decrease the excretion rate of Fluocinolone acetonide which could result in a higher serum level.]
[N02BG07, flupirtine, Fosinopril may decrease the excretion rate of Flupirtine which could result in a higher serum level.]
[R03CC15, formoterol, Formoterol may decrease the antihypertensive activities of Fosinopril.]
[A10AF01, insulin, regular, human, The risk or severity of hypoglycemia can be increased when Fosinopril is combined with Insulin human.]
[N01AB05, trichloroethylene, Trichloroethylene may decrease the antihypertensive activities of Fosinopril.]
[H04AA02, dasiglucagon, Fosinopril may increase the hypotensive activities of Dasiglucagon.]
[A02BA01, cimetidine, Fosinopril may decrease the excretion rate of Cimetidine which could result in a higher serum level.]
[V08CA04, gadoteridol, Fosinopril may decrease the excretion rate of Gadoteridol which could result in a higher serum level.]
[N07CA02, cinnarizine, The risk or severity of hyperkalemia can be increased when Fosinopril is combined with Cinnarizine.]
[S03AA07, ciprofloxacin, The risk or severity of hyperkalemia can be increased when Fosinopril is combined with Ciprofloxacin.]
[L01XA01, cisplatin, Fosinopril may decrease the excretion rate of Cisplatin which could result in a higher serum level.]
[C03DA05, finerenone, Finerenone may increase the excretion rate of Fosinopril which could result in a lower serum level and potentially a reduction in efficacy.]
[V09AB03, ioflupane I-123, Fosinopril may decrease the excretion rate of Ioflupane I-123 which could result in a higher serum level.]
[V09AA01, technetium Tc 99m exametazime, Fosinopril may decrease the excretion rate of Technetium Tc-99m exametazime which could result in a higher serum level.]
[V09AX06, florbetaben f-18, Fosinopril may decrease the excretion rate of Florbetaben (18F) which could result in a higher serum level.]
[R03CC13, clenbuterol, Clenbuterol may decrease the antihypertensive activities of Fosinopril.]
[B01AD11, tenecteplase, The risk or severity of angioedema can be increased when Tenecteplase is combined with Fosinopril.]
[N01BB10, levobupivacaine, The risk or severity of adverse effects can be increased when Fosinopril is combined with Levobupivacaine.]
[N06AA04, clomipramine, Clomipramine may decrease the antihypertensive activities of Fosinopril.]
[N03AE01, clonazepam, Fosinopril may decrease the excretion rate of Clonazepam which could result in a higher serum level.]
[S01EA04, clonidine, The risk or severity of hypotension can be increased when Clonidine is combined with Fosinopril.]
[J05AH02, oseltamivir, Oseltamivir may decrease the excretion rate of Fosinopril which could result in a higher serum level.]
[C03BA03, clopamide, Clopamide may increase the excretion rate of Fosinopril which could result in a lower serum level and potentially a reduction in efficacy.]
[N05AH02, clozapine, Clozapine may decrease the antihypertensive activities of Fosinopril.]
[J01GB12, arbekacin, Fosinopril may decrease the excretion rate of Arbekacin which could result in a higher serum level.]
[C02KB01, metyrosine, Fosinopril may increase the hypotensive activities of Metyrosine.]
[M01AX13, proquazone, The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Proquazone is combined with Fosinopril.]
[M04AC01, colchicine, Fosinopril may decrease the excretion rate of Colchicine which could result in a higher serum level.]
[J01XB01, colistin, Fosinopril may decrease the excretion rate of Colistin which could result in a higher serum level.]
[J01DE02, cefpirome, Cefpirome may decrease the excretion rate of Fosinopril which could result in a higher serum level.]
[N01AB07, desflurane, Desflurane may decrease the antihypertensive activities of Fosinopril.]
[A04AA03, tropisetron, Fosinopril may decrease the excretion rate of Tropisetron which could result in a higher serum level.]
[C04AX28, ifenprodil, Ifenprodil may decrease the antihypertensive activities of Fosinopril.]
[A10BX03, nateglinide, Fosinopril may decrease the excretion rate of Nateglinide which could result in a higher serum level.]
[N02BA16, imidazole-2-hydroxybenzoate, The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Imidazole salicylate is combined with Fosinopril.]
[A10AE04, insulin glargine, The risk or severity of hypoglycemia can be increased when Fosinopril is combined with Insulin glargine.]
[B01AC10, indobufen, The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Indobufen is combined with Fosinopril.]
[J05AB14, valganciclovir, Fosinopril may decrease the excretion rate of Valganciclovir which could result in a higher serum level.]
[C05BB03, invert sugar, Fosinopril may decrease the excretion rate of Invert sugar which could result in a higher serum level.]
[V08AB09, iodixanol, Fosinopril may decrease the excretion rate of Iodixanol which could result in a higher serum level.]
[V08AB05, iopromide, Fosinopril may decrease the excretion rate of Iopromide which could result in a higher serum level.]
[V08AB07, ioversol, Fosinopril may decrease the excretion rate of Ioversol which could result in a higher serum level.]
[V08AB12, ioxilan, Fosinopril may decrease the excretion rate of Ioxilan which could result in a higher serum level.]
[M01AH03, valdecoxib, The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Valdecoxib is combined with Fosinopril.]
[A03AX10, isometheptene, Isometheptene may decrease the antihypertensive activities of Fosinopril.]
[N02CC05, almotriptan, Almotriptan may decrease the antihypertensive activities of Fosinopril.]
[M01AH04, parecoxib, The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Parecoxib is combined with Fosinopril.]
[J02AC02, itraconazole, The risk or severity of hyperkalemia can be increased when Fosinopril is combined with Itraconazole.]
[B01AB12, bemiparin, The risk or severity of hyperkalemia can be increased when Fosinopril is combined with Bemiparin.]
[S01AD03, acyclovir, Acyclovir may decrease the excretion rate of Fosinopril which could result in a higher serum level.]
[N05BA10, ketazolam, Fosinopril may decrease the excretion rate of Ketazolam which could result in a higher serum level.]
[M01AA06, kebuzone, The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Kebuzone is combined with Fosinopril.]
[S01EE04, travoprost, Travoprost may increase the hypotensive activities of Fosinopril.]
[S01EE03, bimatoprost, Fosinopril may increase the hypotensive activities of Bimatoprost.]
[C08CA09, lacidipine, Fosinopril may increase the hypotensive activities of Lacidipine.]
[N03AX09, lamotrigine, The risk or severity of hyperkalemia can be increased when Fosinopril is combined with Lamotrigine.]
[N07BC04, lofexidine, Lofexidine may decrease the antihypertensive activities of Fosinopril.]
[M01AB09, lonazolac, The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Lonazolac is combined with Fosinopril.]
[M02AA31, loxoprofen, The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Loxoprofen is combined with Fosinopril.]
[J01DC08, loracarbef, Loracarbef may decrease the excretion rate of Fosinopril which could result in a higher serum level.]
[C09AA03, lisinopril, The risk or severity of angioedema can be increased when Fosinopril is combined with Lisinopril.]
[A06AD01, magnesium carbonate, Fosinopril may decrease the excretion rate of Magnesium carbonate which could result in a higher serum level.]
[C08CA11, manidipine, Fosinopril may increase the hypotensive activities of Manidipine.]
[A08AA09, mefenorex, Mefenorex may decrease the antihypertensive activities of Fosinopril.]
[C07AA14, mepindolol, The risk or severity of hyperkalemia can be increased when Fosinopril is combined with Mepindolol.]
[J01DH02, meropenem, Fosinopril may decrease the excretion rate of Meropenem which could result in a higher serum level.]
[C04AX01, cyclandelate, The risk or severity of hyperkalemia can be increased when Fosinopril is combined with Cyclandelate.]
[R03CB02, methoxyphenamine, Methoxyphenamine may decrease the antihypertensive activities of Fosinopril.]
[C03DA04, eplerenone, Eplerenone may increase the hyperkalemic activities of Fosinopril.]
[N05AD03, metylperon, Fosinopril may decrease the excretion rate of Melperone which could result in a higher serum level.]
[C03AA07, cyclopenthiazide, The therapeutic efficacy of Fosinopril can be increased when used in combination with Cyclopenthiazide.]
[J05AF07, tenofovir disoproxil, Tenofovir disoproxil may decrease the excretion rate of Fosinopril which could result in a higher serum level.]
[N06AX07, minaprine, Minaprine may increase the hypotensive activities of Fosinopril.]
[S01XA18, cyclosporine, Cyclosporine may decrease the antihypertensive activities of Fosinopril.]
[N06AG02, moclobemide, Moclobemide may increase the hypotensive activities of Fosinopril.]
[C09AA13, moexipril, The risk or severity of angioedema can be increased when Fosinopril is combined with Moexipril.]
[M02AA02, mofebutazone, The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Mofebutazone is combined with Fosinopril.]
[M01AX22, morniflumate, The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Morniflumate is combined with Fosinopril.]
[C03XA02, conivaptan, Conivaptan may increase the excretion rate of Fosinopril which could result in a lower serum level and potentially a reduction in efficacy.]
[C02AC05, moxonidine, Moxonidine may decrease the antihypertensive activities of Fosinopril.]
[G04BE09, vardenafil, Vardenafil may increase the antihypertensive activities of Fosinopril.]
[M01AH05, etoricoxib, The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Etoricoxib is combined with Fosinopril.]
[L01AX04, dacarbazine, Fosinopril may decrease the excretion rate of Dacarbazine which could result in a higher serum level.]
[M03CA01, dantrolene, The risk or severity of hyperkalemia can be increased when Fosinopril is combined with Dantrolene.]
[C02CC04, debrisoquin, Fosinopril may increase the hypotensive activities of Debrisoquine.]
[A04AD11, nabilone, The risk or severity of adverse effects can be increased when Nabilone is combined with Fosinopril.]
[M01AX01, nabumetone, The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Nabumetone is combined with Fosinopril.]
[N07BB05, nalmefene, Fosinopril may decrease the excretion rate of Nalmefene which could result in a higher serum level.]
[B05XA15, potassium lactate, The risk or severity of hyperkalemia can be increased when Potassium lactate is combined with Fosinopril.]
[C07AB12, nebivolol, Fosinopril may increase the hypotensive activities of Nebivolol.]
[S01GX04, nedocromil, Fosinopril may decrease the excretion rate of Nedocromil which could result in a higher serum level.]
[N06AX06, nefazodone, Nefazodone may decrease the antihypertensive activities of Fosinopril.]
[C01DX16, nicorandil, Nicorandil may increase the vasodilatory activities of Fosinopril.]
[L02BB02, nilutamide, Fosinopril may decrease the excretion rate of Nilutamide which could result in a higher serum level.]
[C01CA23, theodrenaline, Theodrenaline may decrease the antihypertensive activities of Fosinopril.]
[C01CA05, norfenefrine, Norfenefrine may decrease the antihypertensive activities of Fosinopril.]
[B01AX05, fondaparinux, Fosinopril may decrease the excretion rate of Fondaparinux which could result in a higher serum level.]
[G04BD08, solifenacin, Solifenacin may decrease the antihypertensive activities of Fosinopril.]
[A07EC03, olsalazine, The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Olsalazine is combined with Fosinopril.]
[N06AA01, desipramine, Desipramine may decrease the antihypertensive activities of Fosinopril.]
[H01BA02, desmopressin, Desmopressin may decrease the antihypertensive activities of Fosinopril.]
[V04CH02, indigo carmine, Fosinopril may decrease the excretion rate of Indigotindisulfonic acid which could result in a higher serum level.]
[J01DH03, ertapenem, Ertapenem may decrease the excretion rate of Fosinopril which could result in a higher serum level.]
[C09XA02, aliskiren, The risk or severity of hypotension, hyperkalemia, and nephrotoxicity can be increased when Aliskiren is combined with Fosinopril.]
[M01AE12, oxaprozin, The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Oxaprozin is combined with Fosinopril.]
[N06BA02, dextroamphetamine, Amphetamine may decrease the antihypertensive activities of Fosinopril.]
[P03AC04, permethrin, Fosinopril may decrease the excretion rate of Permethrin which could result in a higher serum level.]
[N05BA01, diazepam, Fosinopril may decrease the excretion rate of Diazepam which could result in a higher serum level.]
[V03AH01, diazoxide, Diazoxide may increase the hypotensive activities of Fosinopril.]
[N06AA08, dibenzepin, Dibenzepin may decrease the antihypertensive activities of Fosinopril.]
[R05DA08, pholcodine, Fosinopril may decrease the excretion rate of Pholcodine which could result in a higher serum level.]
[S01EC02, dichlorphenamide, Diclofenamide may increase the excretion rate of Fosinopril which could result in a lower serum level and potentially a reduction in efficacy.]
[S01BC03, diclofenac, The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Diclofenac is combined with Fosinopril.]
[J05AD01, foscarnet, Foscarnet may decrease the excretion rate of Fosinopril which could result in a higher serum level.]
[A03AA07, dicyclomine, Fosinopril may decrease the excretion rate of Dicyclomine which could result in a higher serum level.]
[J05AF02, didanosine, Fosinopril may decrease the excretion rate of Didanosine which could result in a higher serum level.]
[C02DG01, pinacidil, Fosinopril may increase the hypotensive activities of Pinacidil.]
[A03AX04, pinaverium, The risk or severity of hyperkalemia can be increased when Fosinopril is combined with Pinaverium.]
[N05AD05, pipamperone, The risk or severity of adverse effects can be increased when Fosinopril is combined with Pipamperone.]
[R03CC07, pirbuterol, Pirbuterol may decrease the antihypertensive activities of Fosinopril.]
[C03CA03, piretanide, Piretanide may increase the excretion rate of Fosinopril which could result in a lower serum level and potentially a reduction in efficacy.]
[A08AA03, diethylpropion, Diethylpropion may decrease the antihypertensive activities of Fosinopril.]
[C08CA03, isradipine, Isradipine may increase the hypotensive activities of Fosinopril.]
[D07XC04, diflucortolone, Fosinopril may decrease the excretion rate of Difluocortolone which could result in a higher serum level.]
[N02BA11, diflunisal, The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Diflunisal is combined with Fosinopril.]
[C01AA05, digoxin, Fosinopril may decrease the excretion rate of Digoxin which could result in a higher serum level.]
[C02DB01, dihydralazine, Fosinopril may increase the hypotensive activities of Dihydralazine.]
[C04AE04, dihydroergocristine, Dihydroergocristine may decrease the antihypertensive activities of Fosinopril.]
[N02CA01, dihydroergotamine, Dihydroergotamine may decrease the antihypertensive activities of Fosinopril.]
[N02AA03, hydromorphone, Hydromorphone may decrease the excretion rate of Fosinopril which could result in a higher serum level.]
[L04AX04, lenalidomide, Lenalidomide may decrease the excretion rate of Fosinopril which could result in a higher serum level.]
[J05AE08, atazanavir, Atazanavir may decrease the excretion rate of Fosinopril which could result in a higher serum level.]
[B01AC21, treprostinil, Treprostinil may increase the hypotensive activities of Fosinopril.]
[H03BC01, potassium perchlorate, The risk or severity of hyperkalemia can be increased when Potassium perchlorate is combined with Fosinopril.]
[V03AB04, pralidoxime, Fosinopril may decrease the excretion rate of Pralidoxime which could result in a higher serum level.]
[C08DB01, diltiazem, Diltiazem may increase the hypotensive activities of Fosinopril.]
[V03AB09, dimercaprol, Fosinopril may decrease the excretion rate of Dimercaprol which could result in a higher serum level.]
[R03CC08, procaterol, Procaterol may decrease the antihypertensive activities of Fosinopril.]
[M02AX03, dimethyl sulfoxide, Fosinopril may decrease the excretion rate of Dimethyl sulfoxide which could result in a higher serum level.]
[N02BB04, propyphenazone, The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Propyphenazone is combined with Fosinopril.]
[M01AB14, proglumetacin, The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Proglumetacin is combined with Fosinopril.]
[C09AA06, quinapril, The risk or severity of angioedema can be increased when Fosinopril is combined with Quinapril.]
[B01AC07, dipyridamole, Dipyridamole may increase the antihypertensive activities of Fosinopril.]
[N06BA11, dexmethylphenidate, Dexmethylphenidate may decrease the antihypertensive activities of Fosinopril.]
[N06AA23, quinupramine, Quinupramine may decrease the antihypertensive activities of Fosinopril.]
[C09AA05, ramipril, The risk or severity of angioedema can be increased when Ramipril is combined with Fosinopril.]
[S01XA23, sirolimus, The risk or severity of adverse effects can be increased when Sirolimus is combined with Fosinopril.]
[R03CC14, reproterol, Reproterol may decrease the antihypertensive activities of Fosinopril.]
[S01AX06, resorcinol, Fosinopril may decrease the excretion rate of Resorcinol which could result in a higher serum level.]
[C01BA03, disopyramide, Disopyramide may decrease the excretion rate of Fosinopril which could result in a higher serum level.]
[N05AX08, risperidone, Fosinopril may increase the hypotensive activities of Risperidone.]
[R06AE09, levocetirizine, Fosinopril may decrease the excretion rate of Levocetirizine which could result in a higher serum level.]
[N01BB09, ropivacaine, The risk or severity of adverse effects can be increased when Ropivacaine is combined with Fosinopril.]
[C03XA01, tolvaptan, Tolvaptan may increase the hyperkalemic activities of Fosinopril.]
[G04BE08, tadalafil, Fosinopril may increase the hypotensive activities of Tadalafil.]
[S01BC05, ketorolac, The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Ketorolac is combined with Fosinopril.]
[C02KX02, ambrisentan, Fosinopril may increase the hypotensive activities of Ambrisentan.]
[C01EB18, ranolazine, Ranolazine may decrease the excretion rate of Fosinopril which could result in a higher serum level.]
[N02BA06, salsalate, The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Salsalate is combined with Fosinopril.]
[R03AC12, salmeterol, Salmeterol may decrease the antihypertensive activities of Fosinopril.]
[H05BA01, salmon calcitonin, Salmon calcitonin may decrease the excretion rate of Fosinopril which could result in a higher serum level.]
[C01CA07, dobutamine, Dobutamine may decrease the antihypertensive activities of Fosinopril.]
[C01CA04, dopamine, Dopamine may decrease the antihypertensive activities of Fosinopril.]
[N06AA16, dothiepin, Dosulepin may decrease the antihypertensive activities of Fosinopril.]
[R07AB01, doxapram, Doxapram may decrease the antihypertensive activities of Fosinopril.]
[N06AA12, doxepin, Doxepin may decrease the antihypertensive activities of Fosinopril.]
[J01AA02, doxycycline, Doxycycline may decrease the excretion rate of Fosinopril which could result in a higher serum level.]
[N01AB08, sevoflurane, Sevoflurane may decrease the antihypertensive activities of Fosinopril.]
[N05AD08, droperidol, Droperidol may decrease the antihypertensive activities of Fosinopril.]
[A08AA10, sibutramine, Fosinopril may decrease the excretion rate of Sibutramine which could result in a higher serum level.]
[V03AG05, sodium phosphate, The risk or severity of nephrotoxicity can be increased when Fosinopril is combined with Sodium phosphate, monobasic.]
[A12CA02, sodium sulfate, Fosinopril may decrease the excretion rate of Sodium sulfate which could result in a higher serum level.]
[C09AA11, spirapril, The risk or severity of angioedema can be increased when Fosinopril is combined with Spirapril.]
[R03DA01, dyphylline, Fosinopril may decrease the excretion rate of Dyphylline which could result in a higher serum level.]
[N02CC01, sumatriptan, Sumatriptan may decrease the antihypertensive activities of Fosinopril.]
[V04CX07, edrophonium, Fosinopril may decrease the excretion rate of Edrophonium which could result in a higher serum level.]
[C07AB13, talinolol, Fosinopril may increase the hypotensive activities of Talinolol.]
[L01AX03, temozolomide, Fosinopril may decrease the excretion rate of Temozolomide which could result in a higher serum level.]
[M01AC02, tenoxicam, The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Tenoxicam is combined with Fosinopril.]
[G04CA03, terazosin, Fosinopril may increase the hypotensive activities of Terazosin.]
[G04BD05, terodiline, The risk or severity of hyperkalemia can be increased when Fosinopril is combined with Terodiline.]
[C07AA16, tertatolol, The risk or severity of hyperkalemia can be increased when Fosinopril is combined with Tertatolol.]
[S01GA02, tetrahydrozoline, Tetryzoline may decrease the antihypertensive activities of Fosinopril.]
[N06AX14, tianeptine, Tianeptine may decrease the antihypertensive activities of Fosinopril.]
[C09AA02, enalapril, The risk or severity of angioedema can be increased when Fosinopril is combined with Enalapril.]
[M01AG02, tolfenamic acid, The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Tolfenamic acid is combined with Fosinopril.]
[N06AG03, toloxatone, Toloxatone may increase the hypotensive activities of Fosinopril.]
[N06BA09, atomoxetine, Atomoxetine may decrease the antihypertensive activities of Fosinopril.]
[N03AX11, topiramate, Topiramate may decrease the excretion rate of Fosinopril which could result in a higher serum level.]
[C03CA04, torsemide, Torasemide may increase the excretion rate of Fosinopril which could result in a lower serum level and potentially a reduction in efficacy.]
[R01AA09, tramazoline, Tramazoline may decrease the antihypertensive activities of Fosinopril.]
[C09AA10, trandolapril, The risk or severity of angioedema can be increased when Fosinopril is combined with Trandolapril.]
[N05CC01, chloral hydrate, Fosinopril may decrease the excretion rate of Chloral hydrate which could result in a higher serum level.]
[R03CC11, tulobuterol, Tulobuterol may decrease the antihypertensive activities of Fosinopril.]
[C02CA06, urapidil, Urapidil may decrease the antihypertensive activities of Fosinopril.]
[S01FB02, ephedrine, Ephedrine may decrease the antihypertensive activities of Fosinopril.]
[N06AX16, venlafaxine, Venlafaxine may decrease the excretion rate of Fosinopril which could result in a higher serum level.]
[C01CX07, xamoterol, Xamoterol may decrease the antihypertensive activities of Fosinopril.]
[S01GA03, xylometazoline, Xylometazoline may decrease the antihypertensive activities of Fosinopril.]
[C08CA12, mepirodipine, Fosinopril may increase the antihypertensive activities of Barnidipine.]
[S01EA01, epinephrine, Epinephrine may decrease the antihypertensive activities of Fosinopril.]
[C09AA15, zofenopril, The risk or severity of angioedema can be increased when Fosinopril is combined with Zofenopril.]
[M01AB04, zomepirac, The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Zomepirac is combined with Fosinopril.]
[N03AX15, zonisamide, Zonisamide may increase the excretion rate of Fosinopril which could result in a lower serum level and potentially a reduction in efficacy.]
[A10AB06, insulin glulisine, human, The risk or severity of hypoglycemia can be increased when Fosinopril is combined with Insulin glulisine.]
[B01AD03, anistreplase, The risk or severity of angioedema can be increased when Anistreplase is combined with Fosinopril.]
[L01XA02, carboplatin, Carboplatin may decrease the excretion rate of Fosinopril which could result in a higher serum level.]
[C02AC02, guanfacine, Guanfacine may decrease the antihypertensive activities of Fosinopril.]
[B01AC11, iloprost, Iloprost may increase the hypotensive activities of Fosinopril.]
[G02AB03, ergonovine, Ergometrine may decrease the antihypertensive activities of Fosinopril.]
[C04AE01, ergoloid mesylates, USP, Ergoloid mesylate may decrease the antihypertensive activities of Fosinopril.]
[N02CA02, ergotamine, Ergotamine may decrease the antihypertensive activities of Fosinopril.]
[L03AX05, pidotimod, Fosinopril may decrease the excretion rate of Pidotimod which could result in a higher serum level.]
[N05CD04, estazolam, Fosinopril may decrease the excretion rate of Estazolam which could result in a higher serum level.]
[A02BC02, pantoprazole, Pantoprazole may decrease the excretion rate of Fosinopril which could result in a higher serum level.]
[G03CA03, estradiol, Fosinopril may decrease the excretion rate of Estradiol which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), The risk or severity of angioedema can be increased when Conjugated estrogens is combined with Fosinopril.]
[J04AK02, ethambutol, Ethambutol may decrease the excretion rate of Fosinopril which could result in a higher serum level.]
[V08CA03, gadodiamide, Gadodiamide may decrease the excretion rate of Fosinopril which could result in a higher serum level.]
[C01CA15, gepefrine, Gepefrine may decrease the antihypertensive activities of Fosinopril.]
[V03AF05, amifostine, Fosinopril may increase the hypotensive activities of Amifostine.]
[C01BD05, ibutilide, Ibutilide may decrease the excretion rate of Fosinopril which could result in a higher serum level.]
[N03AD01, ethosuximide, The risk or severity of hyperkalemia can be increased when Fosinopril is combined with Ethosuximide.]
[M01AC06, meloxicam, The therapeutic efficacy of Fosinopril can be decreased when used in combination with Meloxicam.]
[C01CA01, etilefrine, Etilefrine may decrease the antihypertensive activities of Fosinopril.]
[N01AX07, etomidate, Etomidate may decrease the antihypertensive activities of Fosinopril.]
[L04AD02, tacrolimus, The risk or severity of hyperkalemia can be increased when Fosinopril is combined with Tacrolimus.]
[P01AX07, trimetrexate, Fosinopril may decrease the excretion rate of Trimetrexate which could result in a higher serum level.]
[N06AX12, bupropion, Fosinopril may decrease the excretion rate of Bupropion which could result in a higher serum level.]
[N06AB08, fluvoxamine, Fluvoxamine may decrease the excretion rate of Fosinopril which could result in a higher serum level.]
[L02AE02, leuprolide, Leuprolide may decrease the excretion rate of Fosinopril which could result in a higher serum level.]
[M01CB01, gold sodium thiomalate, The risk or severity of hypotension, nitritoid reactions, facial flushing, nausea, and vomiting can be increased when Fosinopril is combined with Sodium aurothiomalate.]
[B05AA05, dextran, Fosinopril may decrease the excretion rate of Dextran which could result in a higher serum level.]
[V03AF02, dexrazoxane, Dexrazoxane may decrease the excretion rate of Fosinopril which could result in a higher serum level.]
[A16AA01, levocarnitine, Fosinopril may decrease the excretion rate of Levocarnitine which could result in a higher serum level.]
[C08CA02, felodipine, Fosinopril may increase the hypotensive activities of Felodipine.]
[C08EA01, fendiline, The risk or severity of hyperkalemia can be increased when Fosinopril is combined with Fendiline.]
[M01AE04, fenoprofen, The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Fenoprofen is combined with Fosinopril.]
[R03CC04, fenoterol, Fenoterol may decrease the antihypertensive activities of Fosinopril.]
[N02AB03, fentanyl, Fentanyl may decrease the antihypertensive activities of Fosinopril.]
[R03CC02, albuterol, Salbutamol may decrease the antihypertensive activities of Fosinopril.]
[L01BB06, clofarabine, The risk or severity of adverse effects can be increased when Fosinopril is combined with Clofarabine.]
[N07AX03, cevimeline, Cevimeline may decrease the excretion rate of Fosinopril which could result in a higher serum level.]
[G04BD02, flavoxate, Fosinopril may decrease the excretion rate of Flavoxate which could result in a higher serum level.]
[N02BG04, floctafenine, The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Floctafenine is combined with Fosinopril.]
[J02AC01, fluconazole, The risk or severity of hyperkalemia can be increased when Fluconazole is combined with Fosinopril.]
[J02AX01, flucytosine, Fosinopril may decrease the excretion rate of Flucytosine which could result in a higher serum level.]
[V03AB25, flumazenil, Fosinopril may decrease the excretion rate of Flumazenil which could result in a higher serum level.]
[N07CA03, flunarizine, The risk or severity of hyperkalemia can be increased when Fosinopril is combined with Flunarizine.]
[N06AA14, melitracen, Melitracen may decrease the antihypertensive activities of Fosinopril.]
[V03AZ01, ethanol, Ethanol may increase the hypotensive activities of Fosinopril.]
[L01BC09, floxuridine, Floxuridine may decrease the excretion rate of Fosinopril which could result in a higher serum level.]
[N05AF01, flupenthixol, Flupentixol may decrease the antihypertensive activities of Fosinopril.]
[N05CD01, flurazepam, Fosinopril may decrease the excretion rate of Flurazepam which could result in a higher serum level.]
[S01BC04, flurbiprofen, The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Flurbiprofen is combined with Fosinopril.]
[N05AG01, fluspirilene, The risk or severity of hyperkalemia can be increased when Fosinopril is combined with Fluspirilene.]
[L02BB01, flutamide, Fosinopril may decrease the excretion rate of Flutamide which could result in a higher serum level.]
[V04CX02, folic acid, Folic acid may decrease the excretion rate of Fosinopril which could result in a higher serum level.]
[S02AA17, fosfomycin, Fosinopril may decrease the excretion rate of Fosfomycin which could result in a higher serum level.]
[S01AA07, framycetin, Framycetin may decrease the excretion rate of Fosinopril which could result in a higher serum level.]
[L01BC03, tegafur, Fosinopril may decrease the excretion rate of Tegafur which could result in a higher serum level.]
[N06BX17, adrafinil, Adrafinil may decrease the antihypertensive activities of Fosinopril.]
[G01AX06, furazolidone, Furazolidone may increase the hypotensive activities of Fosinopril.]
[C03CA01, furosemide, The risk or severity of renal failure and hypotension can be increased when Furosemide is combined with Fosinopril.]
[N05CF04, eszopiclone, Eszopiclone may decrease the excretion rate of Fosinopril which could result in a higher serum level.]
[C08DA02, gallopamil, The risk or severity of hyperkalemia can be increased when Fosinopril is combined with Gallopamil.]
[S01AD09, ganciclovir, Fosinopril may decrease the excretion rate of Ganciclovir which could result in a higher serum level.]
[N03AA04, barbexaclone, Barbexaclone may increase the hypotensive activities of Fosinopril.]
[C10AB04, gemfibrozil, Fosinopril may decrease the excretion rate of Gemfibrozil which could result in a higher serum level.]
[J01XA03, telavancin, Fosinopril may decrease the excretion rate of Telavancin which could result in a higher serum level.]
[N04BC06, cabergoline, Cabergoline may decrease the antihypertensive activities of Fosinopril.]
[N03AD03, methsuximide, The risk or severity of hyperkalemia can be increased when Fosinopril is combined with Methsuximide.]
[N01AH02, alfentanil, Alfentanil may decrease the antihypertensive activities of Fosinopril.]
[A10BB07, glipizide, Fosinopril may decrease the excretion rate of Glipizide which could result in a higher serum level.]
[N05CM18, dexmedetomidine, Dexmedetomidine may decrease the antihypertensive activities of Fosinopril.]
[C05AE01, nitroglycerin, Fosinopril may increase the hypotensive activities of Nitroglycerin.]
[C02CA04, doxazosin, Fosinopril may increase the hypotensive activities of Doxazosin.]
[L01EX02, sorafenib, Sorafenib may decrease the excretion rate of Fosinopril which could result in a higher serum level.]
[C07AB09, esmolol, Esmolol may increase the hypotensive activities of Fosinopril.]
[M01CB04, aurothioglucose, Fosinopril may decrease the excretion rate of Aurothioglucose which could result in a higher serum level.]
[S01LA03, pegaptanib, Fosinopril may decrease the excretion rate of Pegaptanib which could result in a higher serum level.]
[M01AG01, mefenamic acid, The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Mefenamic acid is combined with Fosinopril.]
[C01DA05, pentaerythritol tetranitrate, Fosinopril may decrease the excretion rate of Pentaerythritol tetranitrate which could result in a higher serum level.]
[S01EX01, guanethidine, Fosinopril may increase the hypotensive activities of Guanethidine.]
[L02AE03, goserelin, Goserelin may decrease the excretion rate of Fosinopril which could result in a higher serum level.]
[N05AD01, haloperidol, Fosinopril may decrease the excretion rate of Haloperidol which could result in a higher serum level.]
[N01AB01, halothane, Halothane may decrease the antihypertensive activities of Fosinopril.]
[N05AH04, quetiapine, Quetiapine may increase the hypotensive activities of Fosinopril.]
[N06BX13, idebenone, Fosinopril may decrease the excretion rate of Idebenone which could result in a higher serum level.]
[A10AD05, insulin aspart, human, The risk or severity of hypoglycemia can be increased when Fosinopril is combined with Insulin aspart.]
[M04AA01, allopurinol, The risk of a hypersensitivity reaction to Allopurinol is increased when it is combined with Fosinopril.]
[C09CA01, losartan, The risk or severity of renal failure, hypotension, and hyperkalemia can be increased when Fosinopril is combined with Losartan.]
[S01XA14, heparin, The risk or severity of hyperkalemia can be increased when Fosinopril is combined with Heparin.]
[G03DC01, allylestrenol, Fosinopril may decrease the excretion rate of Allylestrenol which could result in a higher serum level.]
[A07EC02, mesalamine, The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Mesalazine is combined with Fosinopril.]
[C01CE02, milrinone, Milrinone may decrease the excretion rate of Fosinopril which could result in a higher serum level.]
[N05CA16, hexobarbital, Hexobarbital may increase the hypotensive activities of Fosinopril.]
[R03CC05, hexoprenaline, Hexoprenaline may decrease the antihypertensive activities of Fosinopril.]
[C08CA10, nilvadipine, Fosinopril may increase the hypotensive activities of Nilvadipine.]
[M02AA26, nimesulide, The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Nimesulide is combined with Fosinopril.]
[C09AA04, perindopril, The risk or severity of angioedema can be increased when Fosinopril is combined with Perindopril.]
[C02DB02, hydralazine, Fosinopril may increase the hypotensive activities of Hydralazine.]
[C03AA02, hydroflumethiazide, The therapeutic efficacy of Fosinopril can be increased when used in combination with Hydroflumethiazide.]
[B05XA17, potassium acetate, The risk or severity of hyperkalemia can be increased when Potassium acetate is combined with Fosinopril.]
[S01XA07, aluminum potassium sulfate, The risk or severity of hyperkalemia can be increased when Potassium alum is combined with Fosinopril.]
[A12BA02, potassium citrate, The risk or severity of hyperkalemia can be increased when Potassium citrate is combined with Fosinopril.]
[V03AB33, hydroxocobalamin, Hydroxocobalamin may decrease the excretion rate of Fosinopril which could result in a higher serum level.]
[G04BD06, propiverine, Propiverine may decrease the antihypertensive activities of Fosinopril.]
[B05AA07, hetastarch, Fosinopril may decrease the excretion rate of Hydroxyethyl Starch which could result in a higher serum level.]
[C02AC06, rilmenidine, Rilmenidine may decrease the antihypertensive activities of Fosinopril.]
[R02AX02, ibuprofen, The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Ibuprofen is combined with Fosinopril.]
[B05XA08, sodium acetate, Fosinopril may decrease the excretion rate of Sodium acetate which could result in a higher serum level.]
[L01AA06, ifosfamide, Fosinopril may decrease the excretion rate of Ifosfamide which could result in a higher serum level.]
[N01AH03, sufentanil, Sufentanil may decrease the antihypertensive activities of Fosinopril.]
[N06AA02, imipramine, Imipramine may decrease the antihypertensive activities of Fosinopril.]
[L01CD01, paclitaxel, The risk or severity of adverse effects can be increased when Fosinopril is combined with Paclitaxel.]
[R01AD07, tixocortol, Fosinopril may decrease the excretion rate of Tixocortol which could result in a higher serum level.]
[M03BX02, tizanidine, The risk or severity of hypotension can be increased when Tizanidine is combined with Fosinopril.]
[L01CE01, topotecan, Fosinopril may decrease the excretion rate of Topotecan which could result in a higher serum level.]
[C03BA11, indapamide, The therapeutic efficacy of Indapamide can be increased when used in combination with Fosinopril.]
[S01BC01, indomethacin, The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Indomethacin is combined with Fosinopril.]
[C02CA02, indoramin, Indoramin may decrease the antihypertensive activities of Fosinopril.]
[A11HA07, inositol, Fosinopril may decrease the excretion rate of Inositol which could result in a higher serum level.]
[N06AX17, milnacipran, Fosinopril may decrease the excretion rate of Milnacipran which could result in a higher serum level.]
[S01XA28, varenicline, Fosinopril may decrease the excretion rate of Varenicline which could result in a higher serum level.]
[A10BH01, sitagliptin, The risk or severity of angioedema can be increased when Sitagliptin is combined with Fosinopril.]
[N05BA12, alprazolam, Alprazolam may decrease the excretion rate of Fosinopril which could result in a higher serum level.]
[N05CH02, ramelteon, Fosinopril may decrease the excretion rate of Ramelteon which could result in a higher serum level.]
[A10BH02, vildagliptin, The risk or severity of angioedema can be increased when Vildagliptin is combined with Fosinopril.]
[C07AA01, alprenolol, Fosinopril may increase the hypotensive activities of Alprenolol.]
[C03BA02, quinethazone, The risk or severity of hypotension can be increased when Quinethazone is combined with Fosinopril.]
[V03AB01, ipecac, Fosinopril may decrease the excretion rate of Ipecac which could result in a higher serum level.]
[N06AA13, iprindole, Iprindole may decrease the antihypertensive activities of Fosinopril.]
[N06AF05, iproniazid, Iproniazid may increase the hypotensive activities of Fosinopril.]
[N06AF01, isocarboxazid, Isocarboxazid may increase the hypotensive activities of Fosinopril.]
[S01EC03, dorzolamide, Fosinopril may increase the hypotensive activities of Dorzolamide.]
[R03CC06, isoetharine, Isoetharine may decrease the antihypertensive activities of Fosinopril.]
[C09AA16, imidapril, The risk or severity of angioedema can be increased when Fosinopril is combined with Imidapril.]
[N01AB06, isoflurane, Isoflurane may decrease the antihypertensive activities of Fosinopril.]
[J04AC01, isoniazid, Fosinopril may decrease the excretion rate of Isoniazid which could result in a higher serum level.]
[J05AX05, inosine pranobex, Fosinopril may decrease the excretion rate of Inosine pranobex which could result in a higher serum level.]
[R03CB01, isoproterenol, Isoprenaline may decrease the antihypertensive activities of Fosinopril.]
[C05AE02, isosorbide dinitrate, The risk or severity of adverse effects can be increased when Fosinopril is combined with Isosorbide dinitrate.]
[D10BA01, isotretinoin, Fosinopril may decrease the excretion rate of Isotretinoin which could result in a higher serum level.]
[C04AA01, isoxsuprine, Isoxsuprine may decrease the antihypertensive activities of Fosinopril.]
[S01AA24, kanamycin, Fosinopril may decrease the excretion rate of Kanamycin which could result in a higher serum level.]
[N01AX03, ketamine, Fosinopril may decrease the excretion rate of Ketamine which could result in a higher serum level.]
[C02KD01, ketanserin, Fosinopril may increase the hypotensive activities of Ketanserin.]
[B01AC22, prasugrel, Fosinopril may decrease the excretion rate of Prasugrel which could result in a higher serum level.]
[J02AB02, ketoconazole, The risk or severity of hyperkalemia can be increased when Fosinopril is combined with Ketoconazole.]
[N05AH03, olanzapine, The risk or severity of adverse effects can be increased when Olanzapine is combined with Fosinopril.]
[M02AA10, ketoprofen, The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Ketoprofen is combined with Fosinopril.]
[C01CA22, arbutamine, Arbutamine may decrease the antihypertensive activities of Fosinopril.]
[N04BC09, rotigotine, Rotigotine may decrease the antihypertensive activities of Fosinopril.]
[C07AG01, labetalol, Fosinopril may increase the hypotensive activities of Labetalol.]
[N04BB01, amantadine, Fosinopril may decrease the excretion rate of Amantadine which could result in a higher serum level.]
[C02AA05, deserpidine, Fosinopril may increase the hypotensive activities of Deserpidine.]
[A06AX03, lubiprostone, Fosinopril may decrease the excretion rate of Lubiprostone which could result in a higher serum level.]
[N04BA01, levodopa, The risk or severity of hypotension and orthostatic hypotension can be increased when Fosinopril is combined with Levodopa.]
[C08EX01, lidoflazine, The risk or severity of hyperkalemia can be increased when Fosinopril is combined with Lidoflazine.]
[S01AA21, amikacin, Fosinopril may decrease the excretion rate of Amikacin which could result in a higher serum level.]
[C03DB01, amiloride, The risk or severity of hyperkalemia can be increased when Amiloride is combined with Fosinopril.]
[N02CA07, lisuride, Lisuride may decrease the antihypertensive activities of Fosinopril.]
[N06AA07, lofepramine, Lofepramine may decrease the antihypertensive activities of Fosinopril.]
[A07DA03, loperamide, The risk or severity of hyperkalemia can be increased when Fosinopril is combined with Loperamide.]
[N05BA06, lorazepam, Lorazepam may decrease the excretion rate of Fosinopril which could result in a higher serum level.]
[L01EG01, temsirolimus, The risk or severity of angioedema can be increased when Fosinopril is combined with Temsirolimus.]
[B05XA11, magnesium chloride, Fosinopril may decrease the excretion rate of Magnesium chloride which could result in a higher serum level.]
[G04BX01, magnesium hydroxide, Fosinopril may decrease the excretion rate of Magnesium hydroxide which could result in a higher serum level.]
[V04CC02, magnesium sulfate, The risk or severity of hyperkalemia can be increased when Fosinopril is combined with Magnesium sulfate.]
[L01BA05, pralatrexate, Fosinopril may decrease the excretion rate of Pralatrexate which could result in a higher serum level.]
[V04CX04, mannitol, Mannitol may increase the excretion rate of Fosinopril which could result in a lower serum level and potentially a reduction in efficacy.]
[N06AA21, maprotiline, Fosinopril may decrease the excretion rate of Maprotiline which could result in a higher serum level.]
[C02BB01, mecamylamine, Fosinopril may increase the hypotensive activities of Mecamylamine.]
[M02AA18, meclofenamic acid, The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Meclofenamic acid is combined with Fosinopril.]
[C03BA05, mefruside, Mefruside may increase the excretion rate of Fosinopril which could result in a lower serum level and potentially a reduction in efficacy.]
[B01AB06, nadroparin, The risk or severity of hyperkalemia can be increased when Fosinopril is combined with Nadroparin.]
[B01AB05, enoxaparin, The risk or severity of hyperkalemia can be increased when Fosinopril is combined with Enoxaparin.]
[B01AB04, dalteparin, The risk or severity of hyperkalemia can be increased when Fosinopril is combined with Dalteparin.]
[N06DX01, memantine, Fosinopril may decrease the excretion rate of Memantine which could result in a higher serum level.]
[N02AB02, meperidine, Meperidine may decrease the excretion rate of Fosinopril which could result in a higher serum level.]
[C01CA11, mephentermine, Mephentermine may decrease the antihypertensive activities of Fosinopril.]
[N03AA01, mephobarbital, Methylphenobarbital may increase the hypotensive activities of Fosinopril.]
[N01BB03, mepivacaine, Fosinopril may decrease the excretion rate of Mepivacaine which could result in a higher serum level.]
[G04BX16, tiopronin, Fosinopril may decrease the excretion rate of Tiopronin which could result in a higher serum level.]
[C03BC01, mersalyl, Mersalyl may increase the excretion rate of Fosinopril which could result in a lower serum level and potentially a reduction in efficacy.]
[N05AX13, paliperidone, Paliperidone may decrease the antihypertensive activities of Fosinopril.]
[C01CA09, metaraminol, Metaraminol may decrease the antihypertensive activities of Fosinopril.]
[A10BA02, metformin, The risk or severity of lactic acidosis can be increased when Fosinopril is combined with Metformin.]
[N07BC02, methadone, Methadone may decrease the excretion rate of Fosinopril which could result in a higher serum level.]
[N06BA03, methamphetamine, Metamfetamine may decrease the antihypertensive activities of Fosinopril.]
[J05AF05, lamivudine, Fosinopril may decrease the excretion rate of Lamivudine which could result in a higher serum level.]
[S01EC05, methazolamide, Methazolamide may increase the excretion rate of Fosinopril which could result in a lower serum level and potentially a reduction in efficacy.]
[G02CB05, metergoline, Metergoline may decrease the antihypertensive activities of Fosinopril.]
[H03BB02, methimazole, Fosinopril may decrease the excretion rate of Methimazole which could result in a higher serum level.]
[L01BA04, pemetrexed, Fosinopril may decrease the excretion rate of Pemetrexed which could result in a higher serum level.]
[N05CA15, methohexital, Methohexital may increase the hypotensive activities of Fosinopril.]
[A11HA02, pyridoxine, Pyridoxine may decrease the excretion rate of Fosinopril which could result in a higher serum level.]
[L04AX03, methotrexate, Methotrexate may decrease the excretion rate of Fosinopril which could result in a higher serum level.]
[N05AA02, methotrimeprazine, Methotrimeprazine may decrease the antihypertensive activities of Fosinopril.]
[C01CA10, methoxamine, Methoxamine may decrease the antihypertensive activities of Fosinopril.]
[D05BA02, methoxsalen, Fosinopril may decrease the excretion rate of Methoxsalen which could result in a higher serum level.]
[N02BG09, methoxyflurane, Methoxyflurane may decrease the antihypertensive activities of Fosinopril.]
[C03AA08, methyclothiazide, The therapeutic efficacy of Fosinopril can be increased when used in combination with Methyclothiazide.]
[C02AB01, methyldopa, Fosinopril may increase the hypotensive activities of Methyldopa.]
[V04CG05, methylene blue, Methylene blue may increase the hypotensive activities of Fosinopril.]
[G02AB01, methylergonovine, Methylergometrine may decrease the antihypertensive activities of Fosinopril.]
[N06BA04, methylphenidate, Methylphenidate may decrease the antihypertensive activities of Fosinopril.]
[G03EK01, methyltestosterone, Fosinopril may decrease the excretion rate of Methyltestosterone which could result in a higher serum level.]
[N02CA04, methysergide, Methysergide may decrease the antihypertensive activities of Fosinopril.]
[A03FA01, metoclopramide, Fosinopril may decrease the excretion rate of Metoclopramide which could result in a higher serum level.]
[C03BA08, metolazone, The risk or severity of hypotension can be increased when Metolazone is combined with Fosinopril.]
[C07AB02, metoprolol, Metoprolol may increase the hypotensive activities of Fosinopril.]
[V04CD01, metyrapone, Fosinopril may decrease the excretion rate of Metyrapone which could result in a higher serum level.]
[N06AX03, mianserin, Mianserin may decrease the antihypertensive activities of Fosinopril.]
[N02BB03, aminopyrine, The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Aminophenazone is combined with Fosinopril.]
[B01AB07, parnaparin, The risk or severity of hyperkalemia can be increased when Fosinopril is combined with Parnaparin.]
[N05CD08, midazolam, Fosinopril may decrease the excretion rate of Midazolam which could result in a higher serum level.]
[C01CA17, midodrine, Midodrine may decrease the antihypertensive activities of Fosinopril.]
[B01AB10, tinzaparin, The risk or severity of hyperkalemia can be increased when Fosinopril is combined with Tinzaparin.]
[J05AH01, zanamivir, Fosinopril may decrease the excretion rate of Zanamivir which could result in a higher serum level.]
[C09CA03, valsartan, The risk or severity of renal failure, hypotension, and hyperkalemia can be increased when Fosinopril is combined with Valsartan.]
[D11AX01, minoxidil, Minoxidil may increase the hypotensive activities of Fosinopril.]
[N06BA12, lisdexamfetamine, Lisdexamfetamine may decrease the antihypertensive activities of Fosinopril.]
[L03AC01, aldesleukin, The risk or severity of adverse effects can be increased when Aldesleukin is combined with Fosinopril.]
[C01DX12, molsidomine, Molsidomine may increase the hypotensive activities of Fosinopril.]
[C01BD01, amiodarone, The risk or severity of adverse effects can be increased when Fosinopril is combined with Amiodarone.]
[N06AA09, amitriptyline, Amitriptyline may decrease the antihypertensive activities of Fosinopril.]
[N02AA01, morphine, The risk or severity of adverse effects can be increased when Morphine is combined with Fosinopril.]
[A04AA05, palonosetron, Palonosetron may decrease the excretion rate of Fosinopril which could result in a higher serum level.]
[J01DD06, moxalactam, Latamoxef may decrease the excretion rate of Fosinopril which could result in a higher serum level.]
[L04AB05, certolizumab pegol, Fosinopril may decrease the excretion rate of Certolizumab pegol which could result in a higher serum level.]
[G04BA01, ammonium chloride, The risk or severity of hyperkalemia can be increased when Fosinopril is combined with Ammonium chloride.]
[L04AA06, mycophenolic acid, Fosinopril may decrease the excretion rate of Mycophenolic acid which could result in a higher serum level.]
[N05CA02, amobarbital, Amobarbital may increase the hypotensive activities of Fosinopril.]
[G04CA04, silodosin, The risk or severity of orthostatic hypotension and dizziness can be increased when Fosinopril is combined with Silodosin.]
[N06AA17, amoxapine, Amoxapine may decrease the antihypertensive activities of Fosinopril.]
[C07AA12, nadolol, Fosinopril may increase the hypotensive activities of Nadolol.]
[J01CA04, amoxicillin, Fosinopril may decrease the excretion rate of Amoxicillin which could result in a higher serum level.]
[N04BC04, ropinirole, The risk or severity of adverse effects can be increased when Ropinirole is combined with Fosinopril.]
[V03AB15, naloxone, Fosinopril may decrease the excretion rate of Naloxone which could result in a higher serum level.]
[S01GA01, naphazoline, Naphazoline may decrease the antihypertensive activities of Fosinopril.]
[N06BA01, amphetamine, Amphetamine may decrease the antihypertensive activities of Fosinopril.]
[M02AA12, naproxen, The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Naproxen is combined with Fosinopril.]
[N06AX21, duloxetine, The risk or severity of orthostatic hypotension and syncope can be increased when Fosinopril is combined with Duloxetine.]
[N04BX01, tolcapone, The risk or severity of adverse effects can be increased when Tolcapone is combined with Fosinopril.]
[S03AA01, neomycin, Fosinopril may decrease the excretion rate of Neomycin which could result in a higher serum level.]
[N01AH06, remifentanil, Remifentanil may decrease the antihypertensive activities of Fosinopril.]
[C01CX08, levosimendan, The risk or severity of adverse effects can be increased when Fosinopril is combined with Levosimendan.]
[B01AC17, tirofiban, Fosinopril may decrease the excretion rate of Tirofiban which could result in a higher serum level.]
[N05AX14, iloperidone, Iloperidone may decrease the antihypertensive activities of Fosinopril.]
[J02AA01, amphotericin B, The risk or severity of adverse effects can be increased when Fosinopril is combined with Amphotericin B.]
[S01AA19, ampicillin, Ampicillin may decrease the excretion rate of Fosinopril which could result in a higher serum level.]
[L03AX16, plerixafor, Fosinopril may decrease the excretion rate of Plerixafor which could result in a higher serum level.]
[S01AA23, netilmicin, Fosinopril may decrease the excretion rate of Netilmicin which could result in a higher serum level.]
[N06AX23, desvenlafaxine, Fosinopril may decrease the excretion rate of Desvenlafaxine which could result in a higher serum level.]
[C09CA07, telmisartan, The risk or severity of renal failure, hypotension, and hyperkalemia can be increased when Fosinopril is combined with Telmisartan.]
[J05AB11, valacyclovir, Valaciclovir may decrease the excretion rate of Fosinopril which could result in a higher serum level.]
[C01CE01, inamrinone, Fosinopril may decrease the excretion rate of Amrinone which could result in a higher serum level.]
[N06AF02, nialamide, Nialamide may increase the hypotensive activities of Fosinopril.]
[C08CA04, nicardipine, Fosinopril may increase the hypotensive activities of Nicardipine.]
[C04AE02, nicergoline, Nicergoline may decrease the antihypertensive activities of Fosinopril.]
[C08CA05, nifedipine, The risk or severity of adverse effects can be increased when Fosinopril is combined with Nifedipine.]
[M02AA17, niflumic acid, The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Niflumic acid is combined with Fosinopril.]
[V03AB22, amyl nitrite, The risk or severity of adverse effects can be increased when Fosinopril is combined with Amyl Nitrite.]
[C08CA06, nimodipine, Nimodipine may increase the hypotensive activities of Fosinopril.]
[C08CA07, nisoldipine, Nisoldipine may increase the hypotensive activities of Fosinopril.]
[C08CA08, nitrendipine, Fosinopril may increase the hypotensive activities of Nitrendipine.]
[R07AX01, nitric oxide, The risk or severity of adverse effects can be increased when Nitric Oxide is combined with Fosinopril.]
[J01XE01, nitrofurantoin, The risk or severity of hyperkalemia can be increased when Fosinopril is combined with Nitrofurantoin.]
[N05CF03, zaleplon, Fosinopril may decrease the excretion rate of Zaleplon which could result in a higher serum level.]
[N04BC05, pramipexole, The risk or severity of adverse effects can be increased when Pramipexole is combined with Fosinopril.]
[C02DD01, nitroprusside, Nitroprusside may increase the hypotensive activities of Fosinopril.]
[N01AX13, nitrous oxide, Nitrous oxide may decrease the antihypertensive activities of Fosinopril.]
[C01CA03, norepinephrine, Norepinephrine may decrease the antihypertensive activities of Fosinopril.]
[C02KX01, bosentan, Fosinopril may increase the hypotensive activities of Bosentan.]
[N06AA10, nortriptyline, Nortriptyline may decrease the antihypertensive activities of Fosinopril.]
[G02CA02, nylidrin, Nylidrin may decrease the antihypertensive activities of Fosinopril.]
[B01AB08, reviparin, The risk or severity of hyperkalemia can be increased when Fosinopril is combined with Reviparin.]
[N06AA05, opipramol, Opipramol may decrease the antihypertensive activities of Fosinopril.]
[N02AA02, opium, Fosinopril may decrease the excretion rate of Opium which could result in a higher serum level.]
[R03CB03, metaproterenol, Orciprenaline may decrease the antihypertensive activities of Fosinopril.]
[B01AD07, reteplase, The risk or severity of angioedema can be increased when Reteplase is combined with Fosinopril.]
[G04CA02, tamsulosin, The risk or severity of adverse effects can be increased when Fosinopril is combined with Tamsulosin.]
[J01CF04, oxacillin, Fosinopril may decrease the excretion rate of Oxacillin which could result in a higher serum level.]
[N05BA04, oxazepam, Fosinopril may decrease the excretion rate of Oxazepam which could result in a higher serum level.]
[C07AA02, oxprenolol, Fosinopril may increase the hypotensive activities of Oxprenolol.]
[C01DX03, oxyfedrine, Oxyfedrine may decrease the antihypertensive activities of Fosinopril.]
[S01GA04, oxymetazoline, The therapeutic efficacy of Fosinopril can be decreased when used in combination with Oxymetazoline.]
[S01BC02, oxyphenbutazone, The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Oxyphenbutazone is combined with Fosinopril.]
[J04AA01, aminosalicylic acid, The risk or severity of renal failure can be increased when Aminosalicylic acid is combined with Fosinopril.]
[N05AH05, asenapine, Asenapine may decrease the antihypertensive activities of Fosinopril.]
[B01AB09, danaparoid, The risk or severity of hyperkalemia can be increased when Fosinopril is combined with Danaparoid.]
[J04AB30, capreomycin, Fosinopril may decrease the excretion rate of Capreomycin which could result in a higher serum level.]
[G04BE02, papaverine, The risk or severity of adverse effects can be increased when Fosinopril is combined with Papaverine.]
[C02KC01, pargyline, Pargyline may increase the hypotensive activities of Fosinopril.]
[A07AA06, paromomycin, Paromomycin may decrease the excretion rate of Fosinopril which could result in a higher serum level.]
[G04BD11, fesoterodine, Fosinopril may decrease the excretion rate of Fesoterodine which could result in a higher serum level.]
[C07AA23, penbutolol, Fosinopril may increase the hypotensive activities of Penbutolol.]
[N05AG03, penfluridol, The risk or severity of hyperkalemia can be increased when Fosinopril is combined with Penfluridol.]
[J01CE09, penicillin G procaine, Fosinopril may decrease the excretion rate of Procaine benzylpenicillin which could result in a higher serum level.]
[N05CA01, pentobarbital, Pentobarbital may increase the hypotensive activities of Fosinopril.]
[L01XX08, pentostatin, Fosinopril may decrease the excretion rate of Pentostatin which could result in a higher serum level.]
[C04AD03, pentoxifylline, Pentoxifylline may increase the hypotensive activities of Fosinopril.]
[N04BC02, pergolide, Pergolide may decrease the antihypertensive activities of Fosinopril.]
[C08EX02, perhexiline, The risk or severity of hyperkalemia can be increased when Fosinopril is combined with Perhexiline.]
[G04BX06, phenazopyridine, Phenazopyridine may decrease the excretion rate of Fosinopril which could result in a higher serum level.]
[N06AF03, phenelzine, Phenelzine may increase the hypotensive activities of Fosinopril.]
[N03AA02, phenobarbital, Phenobarbital may increase the hypotensive activities of Fosinopril.]
[C04AX02, phenoxybenzamine, Phenoxybenzamine may decrease the antihypertensive activities of Fosinopril.]
[A08AA01, phentermine, Phentermine may decrease the antihypertensive activities of Fosinopril.]
[V03AB36, phentolamine, Phentolamine may decrease the antihypertensive activities of Fosinopril.]
[M02AA01, phenylbutazone, The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Phenylbutazone is combined with Fosinopril.]
[S01GA05, phenylephrine, Phenylephrine may decrease the antihypertensive activities of Fosinopril.]
[R01BA01, phenylpropanolamine, Phenylpropanolamine may decrease the antihypertensive activities of Fosinopril.]
[S01AE05, levofloxacin, Fosinopril may decrease the excretion rate of Levofloxacin which could result in a higher serum level.]
[B02BA01, vitamin K1, Fosinopril may decrease the excretion rate of Phylloquinone which could result in a higher serum level.]
[J05AB12, cidofovir, Cidofovir may decrease the excretion rate of Fosinopril which could result in a higher serum level.]
[C08CX01, mibefradil, Fosinopril may increase the hypotensive activities of Mibefradil.]
[C07AA03, pindolol, Fosinopril may increase the hypotensive activities of Pindolol.]
[J01CA12, piperacillin, Piperacillin may decrease the excretion rate of Fosinopril which could result in a higher serum level.]
[N06BX03, piracetam, Fosinopril may decrease the excretion rate of Piracetam which could result in a higher serum level.]
[C09CA02, eprosartan, The risk or severity of renal failure, hypotension, and hyperkalemia can be increased when Fosinopril is combined with Eprosartan.]
[S01BC06, piroxicam, The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Piroxicam is combined with Fosinopril.]
[J01DD16, cefditoren, Cefditoren may decrease the excretion rate of Fosinopril which could result in a higher serum level.]
[N02CX01, pizotyline, Pizotifen may decrease the antihypertensive activities of Fosinopril.]
[C09CA04, irbesartan, The risk or severity of renal failure, hypotension, and hyperkalemia can be increased when Fosinopril is combined with Irbesartan.]
[S01XA13, alteplase, The risk or severity of angioedema can be increased when Fosinopril is combined with Alteplase.]
[A10BG02, rosiglitazone, Rosiglitazone may decrease the excretion rate of Fosinopril which could result in a higher serum level.]
[C03AA05, polythiazide, The therapeutic efficacy of Fosinopril can be increased when used in combination with Polythiazide.]
[A10BH03, saxagliptin, The risk or severity of angioedema can be increased when Saxagliptin is combined with Fosinopril.]
[B05XA01, potassium chloride, The risk or severity of hyperkalemia can be increased when Potassium chloride is combined with Fosinopril.]
[V03AB21, potassium iodide, The risk or severity of hyperkalemia can be increased when Potassium Iodide is combined with Fosinopril.]
[A10AD04, insulin lispro, The risk or severity of hypoglycemia can be increased when Fosinopril is combined with Insulin lispro.]
[C07AB01, practolol, Fosinopril may increase the hypotensive activities of Practolol.]
[C02CA01, prazosin, The risk or severity of hypotension can be increased when Prazosin is combined with Fosinopril.]
[H02AB07, prednisone, Fosinopril may decrease the excretion rate of Prednisone which could result in a higher serum level.]
[C01DX02, prenylamine, The risk or severity of hyperkalemia can be increased when Fosinopril is combined with Prenylamine.]
[N03AA03, primidone, Primidone may increase the hypotensive activities of Fosinopril.]
[M04AB01, probenecid, Fosinopril may decrease the excretion rate of Probenecid which could result in a higher serum level.]
[C01BA02, procainamide, Fosinopril may decrease the excretion rate of Procainamide which could result in a higher serum level.]
[S01HA05, procaine, Procaine may increase the hypotensive activities of Fosinopril.]
[L01XB01, procarbazine, Procarbazine may increase the hypotensive activities of Fosinopril.]
[C10AB05, fenofibrate, Fosinopril may decrease the excretion rate of Fenofibrate which could result in a higher serum level.]
[N05AA03, promazine, Promazine may decrease the antihypertensive activities of Fosinopril.]
[R06AD02, promethazine, Fosinopril may decrease the excretion rate of Promethazine which could result in a higher serum level.]
[C01BC03, propafenone, Propafenone may decrease the antihypertensive activities of Fosinopril.]
[A03AB05, propantheline, Fosinopril may decrease the excretion rate of Propantheline which could result in a higher serum level.]
[N05AC01, periciazine, Periciazine may decrease the antihypertensive activities of Fosinopril.]
[N05CM06, propiomazine, Propiomazine may decrease the antihypertensive activities of Fosinopril.]
[N01AX10, propofol, Propofol may decrease the antihypertensive activities of Fosinopril.]
[C07AA05, propranolol, Fosinopril may increase the hypotensive activities of Propranolol.]
[N02CC04, rizatriptan, Rizatriptan may decrease the antihypertensive activities of Fosinopril.]
[B01AC09, epoprostenol, Epoprostenol may increase the hypotensive activities of Fosinopril.]
[N06AA11, protriptyline, Protriptyline may decrease the antihypertensive activities of Fosinopril.]
[R01BA02, pseudoephedrine, Pseudoephedrine may decrease the antihypertensive activities of Fosinopril.]
[N05AX12, aripiprazole, The risk or severity of hypotension can be increased when Aripiprazole is combined with Fosinopril.]
[N07XX07, dalfampridine, Fosinopril may decrease the excretion rate of Dalfampridine which could result in a higher serum level.]
[P02CC01, pyrantel, Fosinopril may decrease the excretion rate of Pyrantel which could result in a higher serum level.]
[J04AK01, pyrazinamide, Pyrazinamide may decrease the excretion rate of Fosinopril which could result in a higher serum level.]
[A12BA05, potassium gluconate, The risk or severity of hyperkalemia can be increased when Potassium gluconate is combined with Fosinopril.]
[C01BA01, quinidine, Fosinopril may decrease the excretion rate of Quinidine which could result in a higher serum level.]
[P01BC01, quinine, Quinine may increase the hypotensive activities of Fosinopril.]
[A02BA02, ranitidine, Fosinopril may decrease the excretion rate of Ranitidine which could result in a higher serum level.]
[C02AA01, rescinnamine, The risk or severity of angioedema can be increased when Fosinopril is combined with Rescinnamine.]
[C02AA02, reserpine, Reserpine may increase the hypotensive activities of Fosinopril.]
[J05AP01, ribavirin, Fosinopril may decrease the excretion rate of Ribavirin which could result in a higher serum level.]
[R03AC05, rimiterol, Rimiterol may decrease the antihypertensive activities of Fosinopril.]
[G02CA01, ritodrine, Ritodrine may decrease the antihypertensive activities of Fosinopril.]
[N02BA05, salicylamide, The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Salicylamide is combined with Fosinopril.]
[A07EC01, sulfasalazine, The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Sulfasalazine is combined with Fosinopril.]
[S01BC08, salicylic acid, The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Salicylic acid is combined with Fosinopril.]
[N05CA06, secobarbital, Secobarbital may increase the hypotensive activities of Fosinopril.]
[N04BD01, selegiline, Selegiline may increase the hypotensive activities of Fosinopril.]
[L01FA03, obinutuzumab, Fosinopril may increase the hypotensive activities of Obinutuzumab.]
[J01GB08, sisomicin, Fosinopril may decrease the excretion rate of Sisomicin which could result in a higher serum level.]
[A12CD01, sodium fluoride, Fosinopril may decrease the excretion rate of Sodium fluoride which could result in a higher serum level.]
[V04CC01, sorbitol, Fosinopril may decrease the excretion rate of Sorbitol which could result in a higher serum level.]
[C07AA07, sotalol, The risk or severity of adverse effects can be increased when Sotalol is combined with Fosinopril.]
[C03DA01, spironolactone, The risk or severity of hyperkalemia can be increased when Spironolactone is combined with Fosinopril.]
[C01DA14, isosorbide mononitrate, The risk or severity of adverse effects can be increased when Fosinopril is combined with Isosorbide mononitrate.]
[D10AX03, azelaic acid, Fosinopril may decrease the excretion rate of Azelaic acid which could result in a higher serum level.]
[M01AE11, tiaprofenic acid, The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Tiaprofenic acid is combined with Fosinopril.]
[C03CC01, ethacrynic acid, Etacrynic acid may increase the excretion rate of Fosinopril which could result in a lower serum level and potentially a reduction in efficacy.]
